This content is machine translated Annual Congress of the American Urological Association (AUA), San Francisco Risk assessment in prostate cancer: what do biomarkers do? Since the implementation of PSA testing, the number of PCa diagnoses has multiplied. Biomarkers are increasingly used to prevent overdiagnosis and overtreatment. New approaches, but also limitations, of microbiological testing…
